We Think That There Are More Issues For Raffles Medical Group (SGX:BSL) Than Just Sluggish Earnings
We Think That There Are More Issues For Raffles Medical Group (SGX:BSL) Than Just Sluggish Earnings
The market wasn't impressed with the soft earnings from Raffles Medical Group Ltd (SGX:BSL) recently. We did some further digging and think they have a few more reasons to be concerned beyond the statutory profit.
這次新加坡交易所萊佛士醫療集團有限公司(SGX:BSL)軟性收益未能打動市場。我們進一步挖掘認爲,除了淨利潤外,他們還有其他一些值得擔憂的原因。
How Do Unusual Items Influence Profit?
非常規項目如何影響利潤?
To properly understand Raffles Medical Group's profit results, we need to consider the S$7.6m gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).
要適當理解萊佛士醫療集團的收益結果,我們需要考慮新幣760萬的非常項目增益。我們無法否認更高的收益通常會讓我們感到樂觀,但我們更希望收益能夠持續。當我們對成千上萬的上市公司進行數據分析時,我們發現某年因非常項目的提升帶來的收益提升往往不會在下一年重複出現。總之,這正是會計術語所意味的。假設這些非常項目在當前年度不再出現,那麼我們預計收益將會較低(在業務增長缺失的情況下)。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
這可能會讓您想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看基於其估計的未來盈利能力的互動圖表。
Our Take On Raffles Medical Group's Profit Performance
我們對萊佛士醫療集團的收益表現的看法
Arguably, Raffles Medical Group's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Raffles Medical Group's true underlying earnings power is actually less than its statutory profit. In further bad news, its earnings per share decreased in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you want to do dive deeper into Raffles Medical Group, you'd also look into what risks it is currently facing. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Raffles Medical Group.
可以說,萊佛士醫療集團的法定收益已被非常項目扭曲,從而提高了收益。因此,我們認爲萊佛士醫療集團的真正核心收益能力可能低於其法定收益。更糟糕的是,其每股收益在過去一年中下降了。當然,就分析其收益而言,我們剛剛只是挖掘表層,人們還可以考慮利潤率、預測增長、投資回報率等其他因素。如果您想更深入地了解萊佛士醫療集團,您還應該調查當前面臨的風險。例如,我們發現了1個警示信號,您應該詳細考慮,以更好地了解萊佛士醫療集團。
This note has only looked at a single factor that sheds light on the nature of Raffles Medical Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
這份筆記僅研究了揭示萊佛士醫療集團收益性質的單一因素。但是,如果您能夠將思維集中在細枝末節上,就會發現更多內容。一些人認爲,高股本回報率是優質業務的良好標誌。因此,您可能希望查看這個免費的高股本回報率公司收藏,或者這個擁有高內部所有權股票清單的清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。